The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
a Zeta was actually in 2002 so we have what 23 years of information on it so that's pretty good but is a Zeta is like the least beneficial of all of them and it usually has to be com combined with other drugs because it's mechanism is it just blocks absorption
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Ezetimibe blocks cholesterol absorption at the intestine and so like it it's less less harmful than all the other drug options here because it's just blocking cholesterol absorption the thing is it has the weakest profile of all these drugs